Table III.

Multivariable regression models for global screening and 10-year CVD risk calculation

	Global screening*			10-year CVD risk calculation
	ORa	95% CIa	p-value	ORa	95% CIa	p-value
Specialty			0.001			0.001
Dermatologists vs rheumatologists	0.33	0.15–0.74	0.007	0.53	0.18–1.54	0.241
Dermatologists vs PCPs	0.14	0.05–0.38	< 0.001	0.05	0.02–0.20	< 0.001
Sex
Men vs women	0.53	0.28–0.97	0.040	—	—	—
Practice setting						0.533
Private vs public	—	—	—	2.01	0.59–6.91	0.266
Private + public vs only public	—	—	—	1.22	0.43–3.45	0.704
Years of experience			0.027			0.047
1–10 years vs resident	0.52	0.15–1.80	0.304	0.68	0.20–2.29	0.534
10–20 years vs resident	0.46	0.13–1.66	0.235	0.28	0.08–1.03	0.056
20–30 years vs resident	1.44	0.43–4.78	0.552	0.92	0.27–3.14	0.898
> 20 years vs resident	1.24	0.37–4.14	0.732	0.35	0.10–1.27	0.111
Patients with psoriasis treated per month			0.426			0.662
5–20 vs < 5	1.71	0.76–3.83	0.193	0.72	0.33–1.57	0.406
> 20 vs < 5	1.75	0.57–5.42	0.33	0.60	1.61–2.22	0.442
Specialized psoriasis outpatient clinic
Yes vs no	2.59	1.01–6.69	0.049	1.95	0.61–6.25	0.264
Research projects related to psoriasis
Yes vs no	2.32	1.03–5.24	0.044	3.30	1.17–9.34	0.024
University teaching including psoriasis
Yes vs no	1.50	0.65–3.48	0.344	1.47	0.51–4.23	0.475

^aVariables with no value in any of the columns are those with a p-value > 0.20 in a first univariable logistic regression and which were not identified as potential confounders, as detailed in methods.

95% CI: 95% confidence interval; CVD: cardiovascular disease; OR: odds ratio; PCP: primary care physician.

^*Defined as screening for smoking, hypertension, dyslipidaemia and diabetes mellitus by the same physician.